Company / Depreciation & Amortization
Cocrystal Pharma, Inc. Depreciation & Amortization History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$190.0K
FY2021
5-year range
$50.0K / $190.0K
FY2017-FY2021
Trend
+93.9%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $50,000 to $190,000 over the past 2 years.
Based on SEC 10-K filings.
$190,000 in FY2021.
Increased from $50,000 to $190,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, depreciation & amortization increased 93.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $190.0K | +93.9% |
| FY2020 | $98.0K | +96.0% |
| FY2019 | $50.0K | -63.9% |
| FY2012 | $138.6K | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026